NO20084326L - Fremgangsmate for fremstilling av [(1R), 2S]-2-aminopropansyre 2-[4-(4-fluor-2-metyl-1H-indol-5-yloksy)-5-metylpyrrolo[2,1-f][1,2,4]triazin-6-yloksy]-1-metyletylester - Google Patents

Fremgangsmate for fremstilling av [(1R), 2S]-2-aminopropansyre 2-[4-(4-fluor-2-metyl-1H-indol-5-yloksy)-5-metylpyrrolo[2,1-f][1,2,4]triazin-6-yloksy]-1-metyletylester

Info

Publication number
NO20084326L
NO20084326L NO20084326A NO20084326A NO20084326L NO 20084326 L NO20084326 L NO 20084326L NO 20084326 A NO20084326 A NO 20084326A NO 20084326 A NO20084326 A NO 20084326A NO 20084326 L NO20084326 L NO 20084326L
Authority
NO
Norway
Prior art keywords
yloxy
methylpyrrolo
indol
fluoro
methyl
Prior art date
Application number
NO20084326A
Other languages
English (en)
Norwegian (no)
Inventor
John E Thornton
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
Jaan A Pesti
Zhongmin Xu
Paul C Lobben
David K Leahy
Jale Muslehiddinoglu
Chiajen Lai
Lori Ann Spangler
Robert P Discordia
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084326(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20084326L publication Critical patent/NO20084326L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20084326A 2006-04-21 2008-10-16 Fremgangsmate for fremstilling av [(1R), 2S]-2-aminopropansyre 2-[4-(4-fluor-2-metyl-1H-indol-5-yloksy)-5-metylpyrrolo[2,1-f][1,2,4]triazin-6-yloksy]-1-metyletylester NO20084326L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21
PCT/US2007/066911 WO2007124332A1 (fr) 2006-04-21 2007-04-19 Procédé de synthèse du [(1r),2s]-2-aminopropionate de 2-[4-(4-fluoro-2-méthyl-1h-indol-5-yloxy)-5-méthylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-méthyléthyle

Publications (1)

Publication Number Publication Date
NO20084326L true NO20084326L (no) 2008-11-18

Family

ID=38357966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084326A NO20084326L (no) 2006-04-21 2008-10-16 Fremgangsmate for fremstilling av [(1R), 2S]-2-aminopropansyre 2-[4-(4-fluor-2-metyl-1H-indol-5-yloksy)-5-metylpyrrolo[2,1-f][1,2,4]triazin-6-yloksy]-1-metyletylester

Country Status (23)

Country Link
US (1) US7671199B2 (fr)
EP (1) EP2010538B1 (fr)
JP (1) JP5203353B2 (fr)
KR (1) KR101423789B1 (fr)
CN (1) CN101472927B (fr)
AR (1) AR060622A1 (fr)
AU (1) AU2007240453B2 (fr)
BR (1) BRPI0710691A2 (fr)
CA (1) CA2650059A1 (fr)
CL (2) CL2007001141A1 (fr)
DK (1) DK2010538T3 (fr)
EA (1) EA019693B1 (fr)
ES (1) ES2399379T3 (fr)
HR (1) HRP20130099T1 (fr)
IL (1) IL194715A (fr)
MX (1) MX2008013232A (fr)
NO (1) NO20084326L (fr)
PE (1) PE20080193A1 (fr)
PL (1) PL2010538T3 (fr)
PT (1) PT2010538E (fr)
SI (1) SI2010538T1 (fr)
TW (1) TWI378100B (fr)
WO (1) WO2007124332A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038648A1 (fr) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Formes cristallines de l'acide [(1r), 2s]-2-aminopropionique 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyle ester
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
EP2376491B1 (fr) 2008-12-19 2015-03-04 Cephalon, Inc. Pyrrolotriazines en tant qu'inhibiteurs d'alk et de jak2
US11860139B2 (en) 2018-10-08 2024-01-02 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) * 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
TWI272271B (en) * 2002-07-19 2007-02-01 Bristol Myers Squibb Co Process for preparing certain pyrrolotriazine compounds
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) * 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
WO2006130657A2 (fr) * 2005-05-31 2006-12-07 Bristol-Myers Squibb Company Procede de reduction stereoselective pour la preparation de composes de pyrrolotriazine
WO2007038648A1 (fr) * 2005-09-27 2007-04-05 Bristol-Myers Squibb Company Formes cristallines de l'acide [(1r), 2s]-2-aminopropionique 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyle ester

Also Published As

Publication number Publication date
HRP20130099T1 (hr) 2013-03-31
IL194715A (en) 2013-10-31
AU2007240453A1 (en) 2007-11-01
ES2399379T3 (es) 2013-04-01
CN101472927A (zh) 2009-07-01
MX2008013232A (es) 2008-10-21
AR060622A1 (es) 2008-07-02
JP5203353B2 (ja) 2013-06-05
US20070249610A1 (en) 2007-10-25
JP2009534413A (ja) 2009-09-24
KR20090008246A (ko) 2009-01-21
EA019693B1 (ru) 2014-05-30
CL2010000554A1 (es) 2010-10-15
CN101472927B (zh) 2012-07-04
US7671199B2 (en) 2010-03-02
CA2650059A1 (fr) 2007-11-01
DK2010538T3 (da) 2013-03-18
TW200808799A (en) 2008-02-16
BRPI0710691A2 (pt) 2011-08-23
PT2010538E (pt) 2013-02-22
EP2010538B1 (fr) 2012-12-05
PE20080193A1 (es) 2008-03-10
EP2010538A1 (fr) 2009-01-07
WO2007124332A1 (fr) 2007-11-01
TWI378100B (en) 2012-12-01
CL2007001141A1 (es) 2008-01-18
SI2010538T1 (sl) 2013-06-28
PL2010538T3 (pl) 2013-04-30
KR101423789B1 (ko) 2014-07-30
AU2007240453B2 (en) 2012-04-12
EA200802171A1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
EP2457913A3 (fr) Composés d'hétéroaryle, compositions associées et procédés de traitement
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
WO2009150137A3 (fr) Composés organiques
IL198116A0 (en) Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
WO2007084391A3 (fr) Composes thiazole et procedes d'utilisation
GEP20125537B (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
MY162022A (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
RS52823B (en) NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
WO2007085895A3 (fr) Inhibiteurs fap
WO2008079339A3 (fr) Composés de tétracycline substituée
JO2848B1 (en) Organic compounds
WO2008036308A3 (fr) Hétérocycles substitués par amino, compositions à base de ceux-ci et procédés de traitement à l'aide de ceux-ci
EA200802050A1 (ru) Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов
MA29857B1 (fr) Derives de triazolopyridine en tant qu'inhibiteurs de lipases et phospholipases
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
NO20076371L (no) Fremgangsmate for fremstilling av fenoliske 4-bifenylylazetidin-2-oner
MX2010007714A (es) Piridinas fusionadas activas como inhibidores de c-met.
EA200801008A1 (ru) Гипохолестеринемические соединения
NO20083642L (no) Dibenzylaminderivater som CETP-inhibitorer
WO2007123939A3 (fr) Nouveaux arylamino n-hétéraryles en tant qu'inhibiteurs de mek
WO2008086122A3 (fr) Dérivés cyclisés en tant qu'inhibiteurs d'eg-5
WO2005105770A3 (fr) Derives de sulfure d'arylphenylamine, d'arylphenylamide, et d'arylphenylether
BRPI0720050A2 (pt) 6-oxo-1,6-diidropirimidin-2-ilas no tratamento de doenças proliferativas
MA32290B1 (fr) Nouvelle classe de spiro pipéridines pour le traitement de maladies neurodégénératives
NO20084326L (no) Fremgangsmate for fremstilling av [(1R), 2S]-2-aminopropansyre 2-[4-(4-fluor-2-metyl-1H-indol-5-yloksy)-5-metylpyrrolo[2,1-f][1,2,4]triazin-6-yloksy]-1-metyletylester

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application